Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.825
+0.005 (0.18%)
At close: Jan 6, 2026, 4:00 PM EST
2.820
-0.005 (-0.18%)
After-hours: Jan 6, 2026, 5:25 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $13.92 million as of January 6, 2026. Its market cap has decreased by -59.63% in one year.
Market Cap
13.92M
Enterprise Value
14.88M
1-Year Change
-59.63%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $13.92M, a decrease of -84.30%. That is a compound annual growth rate of -33.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 13.89M | -1.74% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |